Principal Investigator: Benjamin Oshrine, MD (Johns Hopkins All Children’s Hospital)
This trial is for children and young adults undergoing a bone marrow transplant (BMT) for treatment of leukemia or lymphoma. This research is being done to better understand the process of developing immune tolerance after blood and marrow transplantation (BMT). After BMT, the immune system of the donor gradually learns to recognize the recipient as “self” to avoid problems like graft-versus-host disease, a common complication of BMT. This is called immune tolerance. Researchers hope to determine if one specific type of immune cell, called “myeloid-derived suppressor cells” (MDSCs), are involved in this process and to determine when this cell remerges after transplant. Blood will be collected from study participants undergoing BMT to compare recipients of matched related and unrelated transplants to those receiving haploidentical bone marrow transplants (from half-matched relatives).
https://nationalpcf.org/wp-content/uploads/2018/08/Close-up-image-of-machine-and-bag-for-a-blood-transfusion.jpg6301500Jared Bennetthttps://nationalpcf.org/wp-content/uploads/2019/05/National-Pediatric-Cancer-Foundation-Logo.pngJared Bennett2018-08-07 16:28:522018-08-13 13:41:11Role of myeloid-derived suppressor cells (MDSC) in the development of immune tolerance after allogeneic hematopoietic cell transplantation (alloHCT)
National Pediatric Cancer Foundation (NPCF) is a nonprofit organization dedicated to funding research to eliminate childhood cancer.
Top Rated Charity
The National Pediatric Cancer Foundation has received a perfect 100% score for financial health and transparency and is the top-rated childhood cancer charity in the United States by Charity Navigator.